Y-90 Ibritumomab Tiuxetan as Consolidation Following Three Cycles of Fludarabine-Cyclophosphamide-Rituximab Chemoimmunotherapy in Patients with Relapsed Follicular, Indolent or Mantle-Cell Lymphoma: A Prospective “Dose”-Finding Study.
von Schilling, Christoph, Schwarz, Kathleen, Hess, Georg, Viardot, Andreas, Sandherr, Michael, Krause, Stefan, Simon, Jan P., Roethling, Nadine, Peschel, Christian, Schwaiger, Markus and Scheidhauer, Klemens (2007) Y-90 Ibritumomab Tiuxetan as Consolidation Following Three Cycles of Fludarabine-Cyclophosphamide-Rituximab Chemoimmunotherapy in Patients with Relapsed Follicular, Indolent or Mantle-Cell Lymphoma: A Prospective “Dose”-Finding Study. Blood 110 (11), p. 3426.Date of publication of this fulltext: 19 Dec 2024 13:36
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Blood | ||||
| Publisher: | AMER SOC HEMATOLOGY | ||||
|---|---|---|---|---|---|
| Place of Publication: | WASHINGTON | ||||
| Volume: | 110 | ||||
| Number of Issue or Book Chapter: | 11 | ||||
| Page Range: | p. 3426 | ||||
| Date | 2007 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 68708 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric